The impact of cervical lymph node dissection on acid and duodenogastroesophageal reflux after intrathoracic esophagogastrostomy following transthoracic esophagectomy.


Journal

Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 03 03 2019
accepted: 09 06 2019
pubmed: 21 6 2019
medline: 15 2 2020
entrez: 21 6 2019
Statut: ppublish

Résumé

The aim of this study was to evaluate the impact of cervical lymph node dissection on acid reflux and duodenogastroesophageal reflux (DGER) in patients undergoing transthoracic esophagectomy with gastric tube reconstruction and intrathoracic esophagogastrostomy. Thirty-one patients receiving transthoracic esophagectomy with gastric tube reconstruction by intrathoracic esophagogastrostomy were divided into the following two groups: a two-field lymph node dissection group (2F group) and a three-field lymph node dissection group (3F group). All patients underwent 24-h pH and bilirubin monitoring and gastrointestinal endoscopy at 1 year after surgery. The 24-h pH and bilirubin monitoring results, endoscopic findings, and reflux symptoms were compared between the 2 groups. No acid reflux was observed in the 2F group, whereas it was observed in 6 (40%) patients in the 3F group (p = 0.007). DGER was found in 2 patients (13%) in the 2F group and in 8 (53%) in the 3F group (p = 0.023). Four patients (25%) in the 2F group and 9 (60%) in the 3F group (p = 0.048) had reflux esophagitis. Cervical lymph node dissection increases acid reflux and DGER and can lead to an increase in the incidence of reflux esophagitis in patients undergoing intrathoracic esophagogastrostomy.

Identifiants

pubmed: 31218418
doi: 10.1007/s00595-019-01835-4
pii: 10.1007/s00595-019-01835-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1029-1034

Références

Surg Today. 2007;37(5):379-82
pubmed: 17468818
World J Surg. 2018 Feb;42(2):599-605
pubmed: 28808755
J Thorac Cardiovasc Surg. 2014 Oct;148(4):1224-9
pubmed: 24613171
Ann Surg. 1995 Nov;222(5):654-62
pubmed: 7487213
World J Surg. 2013 Feb;37(2):416-23
pubmed: 23052815
Dig Dis Sci. 1993 Jul;38(7):1297-306
pubmed: 8325190
Am J Gastroenterol. 1992 Sep;87(9):1102-11
pubmed: 1519566
Gastroenterology. 1996 Nov;111(5):1192-9
pubmed: 8898632
J Am Coll Surg. 1998 Mar;186(3):306-12
pubmed: 9510261
Ann Thorac Surg. 1991 Jun;51(6):931-5
pubmed: 2039322
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
J Surg Oncol. 2012 Nov;106(6):742-7
pubmed: 22504922
Ann Thorac Surg. 2013 Jun;95(6):1930-7
pubmed: 23642437

Auteurs

Soichiro Asai (S)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Masahide Fukaya (M)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan. mafukaya@med.nagoya-u.ac.jp.

Kazushi Miyata (K)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Keita Itatsu (K)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Ryoji Miyahara (R)

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kazuhiro Furukawa (K)

Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tomoki Ebata (T)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Masato Nagino (M)

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, 466-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH